UASt regulatory sequences drive expression of an inverted repeat.
The expression of TpiGD10138 under the control of Scer\GAL4elav-C155 leads to a significant and progressive decrease in adult locomotor capacity in negative geotaxis assays, and leads to a small but significant decrease in lifespan, as compared to controls.
Adult expressing TpiGD10138 under the control of Scer\GAL4Act5C.PI exhibit hypoactivity, but do not exhibit any obvious increase in bang sensitivity or heat sensitivity, as compared to controls.
Embryos expressing TpiGD10138 under the control of Scer\GAL4kirre.PU have thinner muscles than normal and unfused myoblasts are present.
Adults expressing TpiGD10138 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Scer\GAL4elav-C155, TpiGD10138 has abnormal locomotor behavior | adult stage | progressive phenotype, enhanceable by Hsap\SNCAUAS.cFa, Scer\GAL4elav-C155
Scer\GAL4elav-C155, TpiGD10138 has short lived phenotype, enhanceable by Hsap\SNCAUAS.cFa, Scer\GAL4elav-C155
TpiGD10138, Scer\GAL4elav-C155 is an enhancer of abnormal locomotor behavior | adult stage | progressive phenotype of Hsap\SNCAUAS.cFa, Scer\GAL4elav-C155
TpiGD10138, Scer\GAL4elav-C155 is an enhancer of short lived phenotype of Hsap\SNCAUAS.cFa, Scer\GAL4elav-C155
The co-expression of TpiGD10138 and Hsap\SNCAScer\UAS.cFa under the control of Scer\GAL4elav-C155 leads to a significant and progressive decrease in adult locomotor capacity (in negative geotaxis assays) and a significant decrease in lifespan; former is more severe than either single expression conditions, whereas the later is only more severe than the TpiGD10138 single expression condition.